Institutional Ownership Ptc Therapeutics, Inc. (PTCT)
This table provides information about the institutional ownership of Ptc Therapeutics, Inc. (PTCT). We have compiled data on the 308 institutions that hold shares in the stock, with a total of 80.1 Million shares, which have been reported (via 13F filing form) to have a value of $4.92 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
686,450
shares
|
$43.3 Million
0.03% of portfolio
|
Q2 2023
Added 34.72%
|
|
|
Man Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
671,513
shares
|
$42.3 Million
0.07% of portfolio
|
Q2 2025
Added 157.42%
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Aug 14, 2025 Q2 2025 |
636,502
shares
|
$40.1 Million
0.5% of portfolio
|
Q2 2025
Added 654.4%
|
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
631,622
shares
|
$39.8 Million
0.05% of portfolio
|
Q2 2025
Added 86.89%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
605,905
shares
|
$38.2 Million
0.05% of portfolio
|
Q2 2025
Added 1.83%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
603,482
shares
|
$38 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.05%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
578,950
shares
|
$36.5 Million
0.01% of portfolio
|
Q2 2025
Reduced 54.4%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
537,776
shares
|
$33.9 Million
0.03% of portfolio
|
Q2 2025
Reduced 27.43%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
537,116
shares
|
$33.8 Million
0.02% of portfolio
|
Q2 2025
Added 30.05%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
527,404
shares
|
$33.2 Million
0.01% of portfolio
|
Q2 2025
Reduced 6.13%
|
|
|
Rockefeller Capital Management L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
463,079
shares
|
$29.2 Million
0.05% of portfolio
|
Q2 2025
Added 1.7%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
453,602
shares
|
$28.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.19%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
438,477
shares
|
$27.6 Million
4.19% of portfolio
|
Q2 2025
Reduced 0.34%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
431,730
shares
|
$27.2 Million
0.0% of portfolio
|
Q2 2025
Added 307.04%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
406,469
shares
|
$25.6 Million
4.49% of portfolio
|
Q2 2025
Added 0.56%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Aug 14, 2025 Q2 2025 |
384,447
shares
|
$24.2 Million
0.06% of portfolio
|
Q2 2025
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
384,402
shares
|
$24.2 Million
0.01% of portfolio
|
Q2 2025
Added 70.97%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
375,939
shares
|
$23.7 Million
1.25% of portfolio
|
Q2 2025
Reduced 35.11%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
338,163
shares
|
$21.3 Million
0.02% of portfolio
|
Q2 2025
Added 14.03%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
303,234
shares
|
$19.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.29%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
288,536
shares
|
$18.2 Million
0.01% of portfolio
|
Q2 2025
Reduced 5.65%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Aug 13, 2025 Q2 2025 |
286,057
shares
|
$18 Million
0.06% of portfolio
|
Q2 2025
Reduced 8.25%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
279,812
shares
|
$17.6 Million
0.0% of portfolio
|
Q2 2025
Added 111.44%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
274,267
shares
|
$17.3 Million
0.03% of portfolio
|
Q1 2025
Added 31.67%
|
|
|
Trexquant Investment LP
Stamford, CT |
Aug 12, 2025 Q2 2025 |
272,774
shares
|
$17.2 Million
0.16% of portfolio
|
Q2 2025
Added 40.75%
|